{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T18:12:01Z","timestamp":1771956721446,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1743-422x-11-110","type":"journal-article","created":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T03:02:36Z","timestamp":1402455756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Inhibition of mTORC1 inhibits lytic replication of Epstein-Barr virus in a cell-type specific manner"],"prefix":"10.1186","volume":"11","author":[{"given":"Amy L","family":"Adamson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandi T","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian D","family":"Siedenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,11]]},"reference":[{"key":"2433_CR1","first-page":"2603","volume-title":"Field's Virology. Volume 2","author":"E Kieff","year":"2007","unstructured":"Kieff E, Rickinson AB: Epstein-Barr virus and its replication. In Field's Virology. Volume 2. 5th edition. Edited by: Knipe DM, Howley PM. Philadelphia: Lippincott Williams & Wilkins; 2007:2603-2654.","edition":"5"},{"key":"2433_CR2","first-page":"2655","volume-title":"Field's Virology. Volume 2","author":"AB Rickinson","year":"2007","unstructured":"Rickinson AB, Kieff E: Epstein-Barr virus. In Field's Virology. Volume 2. 5th edition. Edited by: Knipe DM, Howley PM. Philadelphia: Lippincott Williams & Wilkins; 2007:2655-2700.","edition":"5"},{"key":"2433_CR3","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1128\/JVI.73.8.6551-6558.1999","volume":"73","author":"AL Adamson","year":"1999","unstructured":"Adamson AL, Kenney S: The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein. J Virol 1999, 73: 6551-6558.","journal-title":"J Virol"},{"key":"2433_CR4","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.1128\/JVI.75.13.6228-6234.2001","volume":"75","author":"JJ Swenson","year":"2001","unstructured":"Swenson JJ, Holley-Guthrie E, Kenney SC: Epstein-Barr virus immediate-early protein BRLF1 interacts with CBP, promoting enhanced BRLF1 transactivation. J Virol 2001, 75: 6228-6234. 10.1128\/JVI.75.13.6228-6234.2001","journal-title":"J Virol"},{"key":"2433_CR5","doi-asserted-by":"publisher","first-page":"7748","DOI":"10.1128\/JVI.02608-05","volume":"80","author":"Y Chang","year":"2006","unstructured":"Chang Y, Lee HH, Chen YT, Lu J, Wu SY, Chen CW, Takada K, Tsai CH: Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta. J Virol 2006, 80: 7748-7755. 10.1128\/JVI.02608-05","journal-title":"J Virol"},{"key":"2433_CR6","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1099\/vir.0.2008\/003897-0","volume":"89","author":"YH Lee","year":"2008","unstructured":"Lee YH, Chiu YF, Wang WH, Chang LK, Liu ST: Activation of the ERK signal transduction pathway by Epstein-Barr virus immediate-early protein Rta. J Gen Virol 2008, 89: 2437-2446. 10.1099\/vir.0.2008\/003897-0","journal-title":"J Gen Virol"},{"key":"2433_CR7","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1128\/JVI.74.3.1224-1233.2000","volume":"74","author":"AL Adamson","year":"2000","unstructured":"Adamson AL, Darr D, Holley-Guthrie E, Johnson RA, Mauser A, Swenson J, Kenney S: Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases. J Virol 2000, 74: 1224-1233. 10.1128\/JVI.74.3.1224-1233.2000","journal-title":"J Virol"},{"key":"2433_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bbrc.2005.08.036","volume":"336","author":"AL Adamson","year":"2005","unstructured":"Adamson AL: Effects of SUMO-1 upon Epstein-Barr virus BZLF1 function and BMRF1 expression. Biochem Biophys Res Commun 2005, 336: 22-28. 10.1016\/j.bbrc.2005.08.036","journal-title":"Biochem Biophys Res Commun"},{"key":"2433_CR9","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1128\/JVI.75.5.2388-2399.2001","volume":"75","author":"AL Adamson","year":"2001","unstructured":"Adamson AL, Kenney S: Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. J Virol 2001, 75: 2388-2399. 10.1128\/JVI.75.5.2388-2399.2001","journal-title":"J Virol"},{"key":"2433_CR10","doi-asserted-by":"publisher","first-page":"38803","DOI":"10.1074\/jbc.M405470200","volume":"279","author":"LK Chang","year":"2004","unstructured":"Chang LK, Lee YH, Cheng TS, Hong YR, Lu PJ, Wang JJ, Wang WH, Kuo CW, Li SS, Liu ST: Post-translational modification of Rta of Epstein-Barr virus by SUMO-1. J Biol Chem 2004, 279: 38803-38812. 10.1074\/jbc.M405470200","journal-title":"J Biol Chem"},{"key":"2433_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.virusres.2006.01.004","volume":"119","author":"ST Liu","year":"2006","unstructured":"Liu ST, Wang WH, Hong YR, Chuang JY, Lu PJ, Chang LK: Sumoylation of Rta of Epstein-Barr virus is preferentially enhanced by PIASxbeta. Virus Res 2006, 119: 163-170. 10.1016\/j.virusres.2006.01.004","journal-title":"Virus Res"},{"key":"2433_CR12","doi-asserted-by":"publisher","first-page":"6347","DOI":"10.1038\/sj.onc.1209885","volume":"25","author":"MN Corradetti","year":"2006","unstructured":"Corradetti MN, Guan KL: Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene 2006, 25: 6347-6360. 10.1038\/sj.onc.1209885","journal-title":"Oncogene"},{"key":"2433_CR13","doi-asserted-by":"publisher","first-page":"a011593","DOI":"10.1101\/cshperspect.a011593","volume":"4","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM: mTOR Signaling. Cold Spring Harb Perspect Biol 2012, 4: a011593.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2433_CR14","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1515\/BC.2006.170","volume":"387","author":"SM Schieke","year":"2006","unstructured":"Schieke SM, Finkel T: Mitochondrial signaling, TOR, and life span. Biol Chem 2006, 387: 1357-1361.","journal-title":"Biol Chem"},{"key":"2433_CR15","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1242\/jcs.051011","volume":"122","author":"M Laplante","year":"2009","unstructured":"Laplante M, Sabatini DM: mTOR signaling at a glance. J Cell Sci 2009, 122: 3589-3594. 10.1242\/jcs.051011","journal-title":"J Cell Sci"},{"key":"2433_CR16","doi-asserted-by":"publisher","first-page":"6416","DOI":"10.1038\/sj.onc.1209888","volume":"25","author":"Y Mamane","year":"2006","unstructured":"Mamane Y, Petroulakis E, LeBacquer O, Sonenberg N: mTOR, translation initiation and cancer. Oncogene 2006, 25: 6416-6422. 10.1038\/sj.onc.1209888","journal-title":"Oncogene"},{"issue":"4","key":"2433_CR17","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1158\/1535-7163.MCT-10-0833","volume":"10","author":"O Cen","year":"2011","unstructured":"Cen O, Longnecker R: Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr Virus-related Burkitt's lymphoma. Mol Cancer Ther 2011,10(4):679-686. 10.1158\/1535-7163.MCT-10-0833","journal-title":"Mol Cancer Ther"},{"key":"2433_CR18","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1093\/jnci\/93.20.1519","volume":"93","author":"K Garber","year":"2001","unstructured":"Garber K: Rapamycin may prevent post-transplant lymphoma. J Natl Cancer Inst 2001, 93: 1519. 10.1093\/jnci\/93.20.1519","journal-title":"J Natl Cancer Inst"},{"key":"2433_CR19","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1097\/01.tp.0000260142.38619.9c","volume":"83","author":"M Vaysberg","year":"2007","unstructured":"Vaysberg M, Balatoni CE, Nepomuceno RR, Krams SM, Martinez OM: Rapamycin inhibits proliferation of Epstein-Barr virus-positive B-cell lymphomas through modulation of cell-cycle protein expression. Transplantation 2007, 83: 1114-1121. 10.1097\/01.tp.0000260142.38619.9c","journal-title":"Transplantation"},{"key":"2433_CR20","doi-asserted-by":"publisher","first-page":"e14535","DOI":"10.1371\/journal.pone.0014535","volume":"6","author":"LA Nichols","year":"2011","unstructured":"Nichols LA, Adang LA, Kedes DH: Rapamycin blocks production of KSHV\/HHV8: insights into the anti-tumor activity of an immunosuppressant drug. PLoS One 2011, 6: e14535. 10.1371\/journal.pone.0014535","journal-title":"PLoS One"},{"key":"2433_CR21","doi-asserted-by":"publisher","first-page":"5260","DOI":"10.1128\/JVI.02733-09","volume":"84","author":"NJ Moorman","year":"2010","unstructured":"Moorman NJ, Shenk T: Rapamycin-resistant mTORC1 kinase activity is required for herpesvirus replication. J Virol 2010, 84: 5260-5269. 10.1128\/JVI.02733-09","journal-title":"J Virol"},{"key":"2433_CR22","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1534\/genetics.105.042572","volume":"171","author":"AL Adamson","year":"2005","unstructured":"Adamson AL, Wright N, LaJeunesse DR: Modeling early Epstein-Barr virus infection in Drosophila melanogaster: the BZLF1 protein. Genetics 2005, 171: 1125-1135. 10.1534\/genetics.105.042572","journal-title":"Genetics"},{"key":"2433_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1100\/2012\/347597","volume":"2012","author":"AL Adamson","year":"2012","unstructured":"Adamson AL, LaJeunesse DR: A Study of Epstein-Barr Virus BRLF1 Activity in a Drosophila Model System. Sci World J 2012, 2012: 1-9.","journal-title":"Sci World J"},{"key":"2433_CR24","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1101\/gad.835000","volume":"14","author":"H Zhang","year":"2000","unstructured":"Zhang H, Stallock JP, Ng JC, Reinhard C, Neufeld TP: Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev 2000, 14: 2712-2724. 10.1101\/gad.835000","journal-title":"Genes Dev"},{"key":"2433_CR25","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1101\/gad.845700","volume":"14","author":"S Oldham","year":"2000","unstructured":"Oldham S, Montagne J, Radimerski T, Thomas G, Hafen E: Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin. Genes Dev 2000, 14: 2689-2694. 10.1101\/gad.845700","journal-title":"Genes Dev"},{"key":"2433_CR26","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s007050050574","volume":"144","author":"P Speck","year":"1999","unstructured":"Speck P, Longnecker R: Epstein-Barr virus (EBV) infection visualized by EGFP expression demonstrates dependence on known mediators of EBV entry. Arch Virol 1999, 144: 1123-1137. 10.1007\/s007050050574","journal-title":"Arch Virol"},{"key":"2433_CR27","doi-asserted-by":"publisher","first-page":"8023","DOI":"10.1074\/jbc.M900301200","volume":"284","author":"CC Thoreen","year":"2009","unstructured":"Thoreen CC, Kang SA, Chang JW, Liu Q, Zhang J, Gao Y, Reichling LJ, Sim T, Sabatini DM, Gray NS: An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem 2009, 284: 8023-8032. 10.1074\/jbc.M900301200","journal-title":"J Biol Chem"},{"key":"2433_CR28","doi-asserted-by":"publisher","first-page":"725","DOI":"10.4161\/auto.5.5.8504","volume":"5","author":"CC Thoreen","year":"2009","unstructured":"Thoreen CC, Sabatini DM: Rapamycin inhibits mTORC1, but not completely. Autophagy 2009, 5: 725-726. 10.4161\/auto.5.5.8504","journal-title":"Autophagy"},{"key":"2433_CR29","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1242\/jcs.125773","volume":"126","author":"M Laplante","year":"2013","unstructured":"Laplante M, Sabatini DM: Regulation of mTORC1 and its impact on gene expression at a glance. J Cell Sci 2013, 126: 1713-1719. 10.1242\/jcs.125773","journal-title":"J Cell Sci"},{"key":"2433_CR30","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1128\/JVI.69.7.4158-4165.1995","volume":"69","author":"EA Montalvo","year":"1995","unstructured":"Montalvo EA, Cottam M, Hill S, Wang YJ: YY1 binds to and regulates cis-acting negative elements in the Epstein-Barr virus BZLF1 promoter. J Virol 1995, 69: 4158-4165.","journal-title":"J Virol"},{"key":"2433_CR31","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.71.4.3268-3274.1997","volume":"71","author":"S Zalani","year":"1997","unstructured":"Zalani S, Coppage A, Holley-Guthrie E, Kenney S: The cellular YY1 transcription factor binds a cis-acting, negatively regulating element in the Epstein-Barr virus BRLF1 promoter. J Virol 1997, 71: 3268-3274.","journal-title":"J Virol"},{"key":"2433_CR32","doi-asserted-by":"publisher","first-page":"9398","DOI":"10.1128\/JVI.00974-10","volume":"84","author":"JM Spangle","year":"2010","unstructured":"Spangle JM, Munger K: The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis. J Virol 2010, 84: 9398-9407. 10.1128\/JVI.00974-10","journal-title":"J Virol"},{"key":"2433_CR33","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/sj.emboj.7600597","volume":"24","author":"C O'Shea","year":"2005","unstructured":"O'Shea C, Klupsch K, Choi S, Bagus B, Soria C, Shen J, McCormick F, Stokoe D: Adenoviral proteins mimic nutrient\/growth signals to activate the mTOR pathway for viral replication. EMBO J 2005, 24: 1211-1221. 10.1038\/sj.emboj.7600597","journal-title":"EMBO J"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-11-110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T21:37:41Z","timestamp":1597959461000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-11-110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,11]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2433"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-11-110","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,11]]},"assertion":[{"value":"2 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"110"}}